img

Global Thyroid Cancer Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Thyroid Cancer Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Thyroid Cancer Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thyroid Cancer Treatment market research.
Key companies engaged in the Thyroid Cancer Treatment industry include Baxter, Mylan, Alara, Bristol Myers, Abbott, Teva, App pharmaceuticals and Jerome Stevens, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Thyroid Cancer Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Thyroid Cancer Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Thyroid Cancer Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Baxter
Mylan
Alara
Bristol Myers
Abbott
Teva
App pharmaceuticals
Jerome Stevens
Segment by Type
Surgery
Iodine Therapy
External Radiotherapy
Thyroxin Treatment
Chemotherapy
Drugs

Segment by Application


Hospitals
Oncology centers
Hospital Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Thyroid Cancer Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Cancer Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Surgery
1.2.3 Iodine Therapy
1.2.4 External Radiotherapy
1.2.5 Thyroxin Treatment
1.2.6 Chemotherapy
1.2.7 Drugs
1.3 Market by Application
1.3.1 Global Thyroid Cancer Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Oncology centers
1.3.4 Hospital Pharmacies
1.3.5 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thyroid Cancer Treatment Market Perspective (2018-2033)
2.2 Thyroid Cancer Treatment Growth Trends by Region
2.2.1 Global Thyroid Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Thyroid Cancer Treatment Historic Market Size by Region (2018-2023)
2.2.3 Thyroid Cancer Treatment Forecasted Market Size by Region (2024-2033)
2.3 Thyroid Cancer Treatment Market Dynamics
2.3.1 Thyroid Cancer Treatment Industry Trends
2.3.2 Thyroid Cancer Treatment Market Drivers
2.3.3 Thyroid Cancer Treatment Market Challenges
2.3.4 Thyroid Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thyroid Cancer Treatment Players by Revenue
3.1.1 Global Top Thyroid Cancer Treatment Players by Revenue (2018-2023)
3.1.2 Global Thyroid Cancer Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Thyroid Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thyroid Cancer Treatment Revenue
3.4 Global Thyroid Cancer Treatment Market Concentration Ratio
3.4.1 Global Thyroid Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Cancer Treatment Revenue in 2022
3.5 Thyroid Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Thyroid Cancer Treatment Product Solution and Service
3.7 Date of Enter into Thyroid Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thyroid Cancer Treatment Breakdown Data by Type
4.1 Global Thyroid Cancer Treatment Historic Market Size by Type (2018-2023)
4.2 Global Thyroid Cancer Treatment Forecasted Market Size by Type (2024-2033)
5 Thyroid Cancer Treatment Breakdown Data by Application
5.1 Global Thyroid Cancer Treatment Historic Market Size by Application (2018-2023)
5.2 Global Thyroid Cancer Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Thyroid Cancer Treatment Market Size (2018-2033)
6.2 North America Thyroid Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Thyroid Cancer Treatment Market Size by Country (2018-2023)
6.4 North America Thyroid Cancer Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thyroid Cancer Treatment Market Size (2018-2033)
7.2 Europe Thyroid Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Thyroid Cancer Treatment Market Size by Country (2018-2023)
7.4 Europe Thyroid Cancer Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Cancer Treatment Market Size (2018-2033)
8.2 Asia-Pacific Thyroid Cancer Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Thyroid Cancer Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Thyroid Cancer Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thyroid Cancer Treatment Market Size (2018-2033)
9.2 Latin America Thyroid Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Thyroid Cancer Treatment Market Size by Country (2018-2023)
9.4 Latin America Thyroid Cancer Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Cancer Treatment Market Size (2018-2033)
10.2 Middle East & Africa Thyroid Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Thyroid Cancer Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Thyroid Cancer Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Detail
11.1.2 Baxter Business Overview
11.1.3 Baxter Thyroid Cancer Treatment Introduction
11.1.4 Baxter Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.1.5 Baxter Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Thyroid Cancer Treatment Introduction
11.2.4 Mylan Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 Alara
11.3.1 Alara Company Detail
11.3.2 Alara Business Overview
11.3.3 Alara Thyroid Cancer Treatment Introduction
11.3.4 Alara Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.3.5 Alara Recent Development
11.4 Bristol Myers
11.4.1 Bristol Myers Company Detail
11.4.2 Bristol Myers Business Overview
11.4.3 Bristol Myers Thyroid Cancer Treatment Introduction
11.4.4 Bristol Myers Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.4.5 Bristol Myers Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Thyroid Cancer Treatment Introduction
11.5.4 Abbott Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Thyroid Cancer Treatment Introduction
11.6.4 Teva Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.6.5 Teva Recent Development
11.7 App pharmaceuticals
11.7.1 App pharmaceuticals Company Detail
11.7.2 App pharmaceuticals Business Overview
11.7.3 App pharmaceuticals Thyroid Cancer Treatment Introduction
11.7.4 App pharmaceuticals Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.7.5 App pharmaceuticals Recent Development
11.8 Jerome Stevens
11.8.1 Jerome Stevens Company Detail
11.8.2 Jerome Stevens Business Overview
11.8.3 Jerome Stevens Thyroid Cancer Treatment Introduction
11.8.4 Jerome Stevens Revenue in Thyroid Cancer Treatment Business (2018-2023)
11.8.5 Jerome Stevens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Thyroid Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Surgery
Table 3. Key Players of Iodine Therapy
Table 4. Key Players of External Radiotherapy
Table 5. Key Players of Thyroxin Treatment
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Drugs
Table 8. Global Thyroid Cancer Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Thyroid Cancer Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Thyroid Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Thyroid Cancer Treatment Market Share by Region (2018-2023)
Table 12. Global Thyroid Cancer Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Thyroid Cancer Treatment Market Share by Region (2024-2033)
Table 14. Thyroid Cancer Treatment Market Trends
Table 15. Thyroid Cancer Treatment Market Drivers
Table 16. Thyroid Cancer Treatment Market Challenges
Table 17. Thyroid Cancer Treatment Market Restraints
Table 18. Global Thyroid Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Thyroid Cancer Treatment Market Share by Players (2018-2023)
Table 20. Global Top Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyroid Cancer Treatment as of 2022)
Table 21. Ranking of Global Top Thyroid Cancer Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Thyroid Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Thyroid Cancer Treatment Product Solution and Service
Table 25. Date of Enter into Thyroid Cancer Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Thyroid Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Thyroid Cancer Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Thyroid Cancer Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Thyroid Cancer Treatment Revenue Market Share by Type (2024-2033)
Table 31. Global Thyroid Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Thyroid Cancer Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Thyroid Cancer Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Thyroid Cancer Treatment Revenue Market Share by Application (2024-2033)
Table 35. North America Thyroid Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Thyroid Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Thyroid Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Thyroid Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Thyroid Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Thyroid Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Thyroid Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Thyroid Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Thyroid Cancer Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Thyroid Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Thyroid Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Thyroid Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Thyroid Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Thyroid Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Thyroid Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 50. Baxter Company Detail
Table 51. Baxter Business Overview
Table 52. Baxter Thyroid Cancer Treatment Product
Table 53. Baxter Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 54. Baxter Recent Development
Table 55. Mylan Company Detail
Table 56. Mylan Business Overview
Table 57. Mylan Thyroid Cancer Treatment Product
Table 58. Mylan Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 59. Mylan Recent Development
Table 60. Alara Company Detail
Table 61. Alara Business Overview
Table 62. Alara Thyroid Cancer Treatment Product
Table 63. Alara Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 64. Alara Recent Development
Table 65. Bristol Myers Company Detail
Table 66. Bristol Myers Business Overview
Table 67. Bristol Myers Thyroid Cancer Treatment Product
Table 68. Bristol Myers Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 69. Bristol Myers Recent Development
Table 70. Abbott Company Detail
Table 71. Abbott Business Overview
Table 72. Abbott Thyroid Cancer Treatment Product
Table 73. Abbott Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 74. Abbott Recent Development
Table 75. Teva Company Detail
Table 76. Teva Business Overview
Table 77. Teva Thyroid Cancer Treatment Product
Table 78. Teva Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 79. Teva Recent Development
Table 80. App pharmaceuticals Company Detail
Table 81. App pharmaceuticals Business Overview
Table 82. App pharmaceuticals Thyroid Cancer Treatment Product
Table 83. App pharmaceuticals Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 84. App pharmaceuticals Recent Development
Table 85. Jerome Stevens Company Detail
Table 86. Jerome Stevens Business Overview
Table 87. Jerome Stevens Thyroid Cancer Treatment Product
Table 88. Jerome Stevens Revenue in Thyroid Cancer Treatment Business (2018-2023) & (US$ Million)
Table 89. Jerome Stevens Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thyroid Cancer Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Thyroid Cancer Treatment Market Share by Type: 2022 VS 2033
Figure 3. Surgery Features
Figure 4. Iodine Therapy Features
Figure 5. External Radiotherapy Features
Figure 6. Thyroxin Treatment Features
Figure 7. Chemotherapy Features
Figure 8. Drugs Features
Figure 9. Global Thyroid Cancer Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Thyroid Cancer Treatment Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Oncology centers Case Studies
Figure 13. Hospital Pharmacies Case Studies
Figure 14. Retail Pharmacies Case Studies
Figure 15. Thyroid Cancer Treatment Report Years Considered
Figure 16. Global Thyroid Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Thyroid Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Thyroid Cancer Treatment Market Share by Region: 2022 VS 2033
Figure 19. Global Thyroid Cancer Treatment Market Share by Players in 2022
Figure 20. Global Top Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyroid Cancer Treatment as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Thyroid Cancer Treatment Revenue in 2022
Figure 22. North America Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Thyroid Cancer Treatment Market Share by Country (2018-2033)
Figure 24. United States Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Thyroid Cancer Treatment Market Share by Country (2018-2033)
Figure 28. Germany Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Thyroid Cancer Treatment Market Share by Region (2018-2033)
Figure 36. China Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Thyroid Cancer Treatment Market Share by Country (2018-2033)
Figure 44. Mexico Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Thyroid Cancer Treatment Market Share by Country (2018-2033)
Figure 48. Turkey Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Thyroid Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Baxter Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 51. Mylan Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 52. Alara Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 53. Bristol Myers Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 54. Abbott Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 55. Teva Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 56. App pharmaceuticals Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 57. Jerome Stevens Revenue Growth Rate in Thyroid Cancer Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed